SOLUTIONS - Drug-eluting Implants

Celanese works closely with pharmaceutical companies to improve patient outcomes by innovating new long-acting dosage forms. In a wide range of active pharmaceutical ingredients (APIs), we provide a customized approach to help our clients take full advantage of the products and services we offer to create their next drug product. Drug-eluting implants VitalDose(R) Ethylene-vinyl acetate copolymers (EVA) are used to create drug-eluting implants across many clinical segments, including but not limited to oncology, infectious disease, central nervous system disorders, ophthalmology, and Women's Health. These devices improve clinical outcomes and healthcare economics through better dosing and improved patient compliance. VitalDose(R) EVA is a flexible platform compatible with small molecules as well as biologics; and zero or first-order release profiles can be achieved with simple design configurations.